Clinical Trial Update: A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) [Phase 3]

View source ↗

Summary

Phase 3 trial update on efficacy and safety of tocilizumab in systemic sclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Systemic Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2019-04-03